Michael Matly

Michael Matly is the Co-Founder and Managing Partner of 111° West Capital, an early-stage venture capital firm based in the San Francisco Bay Area. A trained physician holding an M.D., he previously founded Hayati Commercial Brokers LLC before transitioning into early-stage healthcare venture investing. Through 111° West Capital, Matly has directed seed-stage capital into several notable healthcare technology and service companies, participating in funding rounds for Arine ($29 million in 2022), TigerConnect ($45 million in 2020), and Pure Life Renal ($20 million in 2014). He recently expanded the firm's capital base, signing official SEC fundraising filings for 111 West Capital ACS LLC in January 2025 and 111 West Capital Fund II LP in May 2025. His current investment focus centers on seed-stage opportunities across medical devices, pharmaceuticals, biotechnology, artificial intelligence, and health information technology.